Feeds

UK drugs trial hospitalises six

Intensive care for 'seriously ill' men

The next step in data security

Six drug trial volunteers who were given an anti-inflammatory drug at a private research unit based at London's Northwick Park Hospital are in intensive care after suffering a "reaction", the BBC reports.

The six were given TGN1412 - "designed to treat conditions such as rheumatoid arthritis and leukaemia" - on Monday. Within hours they were hospitalised after suffering "an inflammatory response which affects some organs of the body", as Northwick's intensive care director Ganesh Suntharalingam put it.

Suntharalingam explained that two of the men were in a critical condition, while the remainder were "serious but showing some signs of improvement".

The girlfriend of one of the men described her 28-year-old boyfriend's face as so swollen he "looks like the Elephant Man". Myfanwy Marshall told the BBC: "His friends cannot even face seeing him. I have to stay there because I'm looking beyond all the wires and the puffiness. This is not leukaemia, this is not pneumonia, this is not something they know how to deal with."

Parexel, the firm behind the trial, said it had followed guidelines and that such cases were extremely rare. The company's Professor Herman Scholtz said: "When the adverse drug reaction occurred, the Parexel clinical pharmacology medical team responded swiftly to stop the study procedures immediately."

The drug's German-based manufacturer, TeGenero, said the reactions were "completely unexpected and did not reflect results from initial laboratory studies".

The Medicines and Healthcare products Regulatory Agency (MHRA), meanwhile, immediately withdrew the trial's authorisation and issued an international warning against testing. Its inspectors have visited the unit and are consulting the local health authority, Department of Health and police with regard to the matter.

According to the BBC, the drug had already been tested on animals and cleared for human trials. ®

Choosing a cloud hosting partner with confidence

More from The Register

next story
SCREW YOU, Russia! NASA lobs $6.8bn at Boeing AND SpaceX to run space station taxis
Musk charging nearly half as much as Boeing for crew trips
Boffins say they've got Lithium batteries the wrong way around
Surprises at the nano-scale mean our ideas about how they charge could be all wrong
Thought that last dinosaur was BIG? This one's bloody ENORMOUS
Weighed several adult elephants, contend boffins
Edge Research Lab to tackle chilly LOHAN's final test flight
Our US allies to probe potential Vulture 2 servo freeze
Europe prepares to INVADE comet: Rosetta landing site chosen
No word yet on whether backup site is labelled 'K'
India's MOM Mars mission makes final course correction
Mangalyaan probe will feel the burn of orbital insertion on September 24th
Cracked it - Vulture 2 power podule fires servos for 4 HOURS
Pixhawk avionics juice issue sorted, onwards to Spaceport America
City hidden beneath England's Stonehenge had HUMAN ABATTOIR. And a pub
Boozed-up ancients drank beer before tearing corpses apart
prev story

Whitepapers

Providing a secure and efficient Helpdesk
A single remote control platform for user support is be key to providing an efficient helpdesk. Retain full control over the way in which screen and keystroke data is transmitted.
WIN a very cool portable ZX Spectrum
Win a one-off portable Spectrum built by legendary hardware hacker Ben Heck
Storage capacity and performance optimization at Mizuno USA
Mizuno USA turn to Tegile storage technology to solve both their SAN and backup issues.
High Performance for All
While HPC is not new, it has traditionally been seen as a specialist area – is it now geared up to meet more mainstream requirements?
Security and trust: The backbone of doing business over the internet
Explores the current state of website security and the contributions Symantec is making to help organizations protect critical data and build trust with customers.